Abstract

Objective: The purpose of this study was to investigate factors related to early quality of life (QOL) three months after surgery in breast cancer patients with axillary lymph node dissection. Methods: The subjects of this study were 195 consecutive patients who underwent axillary lymph node dissection for breast cancer. Age, body mass index, level of lymph node dissection, marriage, children, co-resident household members, neoadjuvant chemotherapy, postoperative chemotherapy, postoperative hormonal therapy, postoperative radiotherapy, upper limb function (disabilities of the arm, shoulder, and hand (DASH)), and QOL (European Organization for the Treatment and Research of Cancer Quality of Life Questionnaire (EORTC QLQ-C30)) were evaluated. For each item of the EORTC QLQ-C30, compared with preoperative status and three months after surgery, those who improved or remained unchanged in the three months after surgery were classified as the maintenance and improved groups, and those with worsening status were classified as the worsened group. Results: Age, level of lymph node dissection, DASH, neoadjuvant chemotherapy, postoperative chemotherapy, and postoperative radiotherapy were significantly associated with QOL (p < 0.05). Conclusions: The early QOL of postoperative patients with breast cancer is affected by multiple factors, such as upper limb function and postoperative chemotherapy, and thus comprehensive intervention is required.

Highlights

  • Breast cancer is the most frequently diagnosed cancer and the most common cause of cancer-related death in females worldwide [1]

  • We investigated factors related to early quality of life (QOL) three months after surgery in breast cancer patients with axillary lymph node dissection

  • In patients undergoing breast cancer surgery, QLQ-C30 changes up to three months after surgery showed that the physical, role, emotional, and social functions of the overall condition and functional scales were relatively improved

Read more

Summary

Introduction

Breast cancer is the most frequently diagnosed cancer and the most common cause of cancer-related death in females worldwide [1]. The number of breast cancer patients continues to increase. In Japan, 5- and 10-year relative survival was improved by. 2.8% and 2.4% respectively, from 1993 to 2006 in patients with breast cancer due to advances in cancer treatment [2]. Advances in diagnosis and treatment have reduced mortality and improved survival rates in breast cancer patients. Patient-centred approaches are being emphasised in healthcare systems, and patient quality of life (QOL) is important. The QOL of cancer patients is a subjective assessment of physical, psychological, social, and spiritual well-being factors [3,4]. In QOL evaluation of cancer patients, the Medical Outcomes Study 36-Item Short-Form Health Survey [5], widely used for chronic

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call